News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): European Medicines Agency European Medicines Evaluation Agency Recommends Orphan Drug Status for Elafin in the Treatment of Esophagus Carcinoma


11/16/2009 10:16:17 AM

IRVINE, Calif. & KIEL, Germany--(BUSINESS WIRE)--Proteo, Inc. (OTCBB: PTEO; Frankfurter Freiverkehr: WKN: 925981) and its wholly-owned subsidiary Proteo Biotech AG announced today:

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES